The label free detection market is projected to grow from USD 0.58 billion in 2026 to USD 0.85 billion by 2031, at a CAGR of 8.1% during the forecast period.
Danaher Corporation (US), Sartorius AG (Germany), and Agilent Technologies, Inc. (US) are the key players in this market.
To know about the assumptions considered for the study download the pdf brochure
These market players have adopted various strategies, including product portfolio expansion, strategic collaborations, investments, technological advancements in biosensing platforms, and product and service development, to strengthen their market positions. In May 2026, Cytiva introduced the next-generation Biacore 8S and 8S+ systems for high-throughput biomolecular interaction analysis. The systems integrate automated plate handling and support screening of up to 384 proteins in approximately 15 minutes.
In May 2025, Sartorius AG launched the Octet R8e system, which features enhanced bio-layer interferometry technology for high-sensitivity biomolecular interaction analysis. The instrument supports detection of low-molecular-weight analytes, 384-well microplates, sample volumes as low as 40 µL, and automated analysis lasting up to 16 hours.
Danaher Corporation (US): Danaher operates in the label free detection market primarily through Cytiva, which offers surface plasmon resonance (SPR)-based instruments for real-time biomolecular interaction analysis. Its Biacore portfolio includes Biacore 8S, Biacore 8S+, Biacore 8K+, and Biacore 1 series systems for binding kinetics, affinity measurement, epitope binning, and antibody characterization. The company also provides sensor chips, immobilization reagents, and Biacore Insight software to support assay development and data interpretation. Its high-throughput SPR platforms support drug discovery, biologics characterization, and quality control workflows, strengthening its position in the label free detection market.
Sartorius AG (Germany): Sartorius provides label free detection solutions through its Octet portfolio, which uses bio-layer interferometry (BLI) technology to analyze biomolecular interactions. Its product range includes Octet R2, R4, R8, RH16, and RH96 systems designed for different throughput requirements. These platforms support protein quantitation, binding kinetics, affinity analysis, and antibody screening. Sartorius also offers application-specific biosensors, assay kits, and analytical software for streamlined experimental workflows. The company's emphasis on automated high-throughput analysis and compatibility with complex biological samples supports its position in biopharmaceutical research, biologics development, and process characterization.
Agilent Technologies, Inc. (US): Agilent participates in the label free detection market through its xCELLigence Real-Time Cell Analysis (RTCA) portfolio, which uses electrical impedance to monitor cellular responses without molecular labeling. Its xCELLigence RTCA eSight platform combines impedance measurements with live-cell imaging, while the RTCA HT system enables high-throughput cellular screening. These instruments support applications such as cell proliferation, cytotoxicity, immune cell killing, and drug response evaluation.
Market Ranking
The label free detection market is consolidated, with established life sciences companies maintaining strong market positions through extensive product portfolios, advanced biosensing technologies, strategic acquisitions, and integrated analytical solutions. Key players include Danaher Corporation (US), Sartorius AG (Germany), and Agilent Technologies, Inc. (US). Danaher offers surface plasmon resonance (SPR)-based Biacore systems through Cytiva for binding kinetics, affinity analysis, and antibody characterization. Sartorius provides Octet bio-layer interferometry (BLI) platforms for high-throughput biomolecular interaction analysis and protein quantitation. Agilent Technologies offers xCELLigence real-time cell analysis systems for impedance-based cellular monitoring and drug response studies. Collectively, these companies strengthen the label free detection market through technological innovation, extensive consumables portfolios, automated analytical workflows, and established global distribution networks.
Related Reports:
Label Free Detection Market by Offering (Instrument [Surface Plasmon Resonance, Bio-layer Interferometry], Consumables [Biosensor, Microplates], Software), Technology (BIL, ITC), Application (Screening, Concentration), End User - Global Forecast to 2031
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE